Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06376162
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-03-28
Brief Title:
Ziftomenib in Combination With Chemotherapy for Children With RelapsedRefractory Acute Leukemia
Sponsor:
LLS PedAL Initiative LLC
Organization:
LLS PedAL Initiative LLC
Organization Data
Organization:
LLS PedAL Initiative LLC
Class:
OTHER
Study ID:
ITCC-101APAL2020K
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LLS PedAL Initiative LLC
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Kura Oncology | UNKNOWN |